Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | REZI | MBX |
|---|---|---|
| Price | $18.56 | $58.54 |
| Change today | ▲ 1.14% | ▲ 0.05% |
| Market cap | $2.82B | $2.82B |
| Return, 3 months | -17.8% | -5.6% |
| Return, year to date | -24.1% | +85.6% |
| Return, 1 year | -37.8% | +260.0% |
| P/E (TTM) | 7.3 | -24.7 |
| P/B | 1.1 | 6.9 |
| P/E percentile vs own 5y | 21st | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +88.6% | +69.6% |
| Analyst buy share | 75% | 100% |
| RSI (14) | 42 | 46 |
| 30-day volatility | 28.7% | 47.8% |
| Max drawdown, 1 year | -41.5% | -37.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
